journal article·2014-04-22Open access

Dynamic Magnetic Fields Remote-Control Apoptosis via Nanoparticle Rotation

Enming Zhang, Moritz F. Kircher, Martin Koch, Lena Eliasson, S. Nahum Goldberg, Erik Renström

ACS Nano· Volume 8· Issue 4

Abstract

The ability to control the movement of nanoparticles remotely and with high precision would have far-reaching implications in many areas of nanotechnology. We have designed a unique dynamic magnetic field (DMF) generator that can induce rotational movements of superparamagnetic iron oxide nanoparticles (SPIONs). We examined whether the rotational nanoparticle movement could be used for remote induction of cell death by injuring lysosomal membrane structures. We further hypothesized that the shear forces created by the generation of oscillatory torques (incomplete rotation) of SPIONs bound to lysosomal membranes would cause membrane permeabilization, lead to extravasation of lysosomal contents into the cytoplasm, and induce apoptosis. To this end, we covalently conjugated SPIONs with antibodies targeting the lysosomal protein marker LAMP1 (LAMP1-SPION). Remote activation of slow rotation of LAMP1-SPIONs significantly improved the efficacy of cellular internalization of the nanoparticles. LAMP1-SPIONs then preferentially accumulated along the membrane in lysosomes in both rat insulinoma tumor cells and human pancreatic beta cells due to binding of LAMP1-SPIONs to endogenous LAMP1. Further activation of torques by the LAMP1-SPIONs bound to lysosomes resulted in rapid decrease in size and number of lysosomes, attributable to tearing of the lysosomal membrane by the shear force of the rotationally activated LAMP1-SPIONs. This remote activation resulted in an increased expression of early and late apoptotic markers and impaired cell growth. Our findings suggest that DMF treatment of lysosome-targeted nanoparticles offers a noninvasive tool to induce apoptosis remotely and could serve as an important platform technology for a wide range of biomedical applications.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Characterization and Applications of Magnetic Nanoparticles · Nanoparticle-Based Drug Delivery · Microfluidic and Bio-sensing Technologies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Clinical Sciences Malmö, Lund University, Malmö 205 02, Sweden

Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, United States

Department of Radiology, Weill Cornell Medical College, New York, New York 10038, United States

Center for Molecular Imaging and Nanotechnology, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, United States

Stetter Elektronik, Seeheim-Jugenheim, Hessen 64342, Germany

Laboratory for Minimally Invasive Tumor Therapies, Department of Radiology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, Massachusetts 02215, United States

Division of Image-guided Therapy and Interventional Oncology, Department of Radiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel

References (43)

Show source-provided references
1. Gaster R. S. · Nat. Med. · 2009 · 15 · 132710.1038/nm.2032 ↗
2. Haun J. B. · Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. · 2010 · 2 · 291
3. Haun J. B. · Sci. Transl. Med. · 2011 · 3 · 71ra16
4. Haun J. B. · ACS Nano · 2011 · 5 · 320410.1021/nn200333m ↗
5. Kircher M. F. · Nat. Rev. Clin. Oncol. · 2011 · 67710.1038/nrclinonc.2011.141 ↗
6. Kircher M. F. · Cancer Res. · 2003 · 63 · 8122
7. Kircher M. F. · Radiology · 2012 · 264 · 34910.1148/radiol.12111703 ↗
8. Kircher M. F. · Radiology · 2012 · 263 · 63310.1148/radiol.12102394 ↗
9. Grimm J. · Radiologe · 2007 · 47 · 2510.1007/s00117-006-1449-5 ↗
10. Kozissnik B. · Int. J. Hyperthermia · 2013 · 29 · 70610.3109/02656736.2013.837200 ↗
11. Laurent S. · Adv. Colloid Interface Sci. · 2011 · 166 · 810.1016/j.cis.2011.04.003 ↗
12. Guo M. · Biomaterials · 2011 · 32 · 18510.1016/j.biomaterials.2010.09.077 ↗
13. Wahajuddin · Int. J. Nanomed. · 2012 · 7 · 344510.2147/IJN.S30320 ↗
14. Creixell M. · ACS Nano · 2011 · 5 · 712410.1021/nn201822b ↗
15. Domenech M. · ACS Nano · 2013 · 7 · 509110.1021/nn4007048 ↗
16. Dobson J. · Nat. Nanotechnol. · 2008 · 3 · 13910.1038/nnano.2008.39 ↗
17. Corchero J. · Trends Biotechnol. · 2009 · 27 · 46810.1016/j.tibtech.2009.04.003 ↗
18. Kumar C. S. · Adv. Drug Delivery Rev. · 2011 · 63 · 78910.1016/j.addr.2011.03.008 ↗
19. Wust P. · Lancet Oncol. · 2002 · 3 · 48710.1016/S1470-2045(02)00818-5 ↗
20. Lee J. H. · Nat. Nanotechnol. · 2011 · 6 · 41810.1038/nnano.2011.95 ↗
21. Ahmed M. · Radiology · 2011 · 258 · 35110.1148/radiol.10081634 ↗
22. Gruttner C. · J. Magn. Magn. Mater. · 2007 · 311 · 18110.1016/j.jmmm.2006.10.1151 ↗
23. El-Dakdouki M. H. · Biomacromolecules · 2012 · 13 · 114410.1021/bm300046h ↗
24. Xu H. F. · J. Nanosci. Nanotechnol. · 2010 · 10 · 740610.1166/jnn.2010.2830 ↗
25. Martin A. L. · J. Nanopart. Res. · 2010 · 12 · 159910.1007/s11051-009-9681-3 ↗
26. Eto K. · Am. J. Physiol. Endocrinol. Metab. · 2003 · 285 · E26210.1152/ajpendo.00542.2002 ↗
27. Cirman T. · J. Biol. Chem. · 2004 · 279 · 357810.1074/jbc.M308347200 ↗
28. Mannix R. J. · Nat. Nanotechnol. · 2008 · 3 · 3610.1038/nnano.2007.418 ↗
29. Cho M. H. · Nat. Mater. · 2012 · 11 · 103810.1038/nmat3430 ↗
30. Tseng P. · Nat. Methods · 2012 · 9 · 111310.1038/nmeth.2210 ↗
31. Ivkov R. · Clin. Cancer Res. · 2005 · 11 · 7093s10.1158/1078-0432.CCR-1004-0016 ↗
32. Huang H. · Nat. Nanotechnol. · 2010 · 5 · 60210.1038/nnano.2010.125 ↗
33. Burckhardt C. J. · PLoS Pathog. · 2009 · 5 · e100062110.1371/journal.ppat.1000621 ↗
34. Tomasini M. D. · Exp. Biol. Med. (Maywood, NJ, U.S.) · 2010 · 235 · 18110.1258/ebm.2009.009187 ↗
35. Ghosh D. · Nat. Nanotechnol. · 2012 · 7 · 67710.1038/nnano.2012.146 ↗
36. Gupta A. K. · Biomaterials · 2005 · 26 · 156510.1016/j.biomaterials.2004.05.022 ↗
37. Bogart L. K. · ACS Nano · 2012 · 6 · 596110.1021/nn300868z ↗
38. Schulze K. · J. Nanosci. Nanotechnol. · 2006 · 6 · 282910.1166/jnn.2006.484 ↗
39. Amstad E. · Nano Lett. · 2011 · 11 · 166410.1021/nl2001499 ↗
40. Daniel W. A. · Eur. Neuropsychopharmacol. · 1999 · 9 · 48310.1016/S0924-977X(99)00034-6 ↗
41. Kornhuber J. · J. Cell. Physiol. · 2010 · 224 · 15210.1002/jcp.22112 ↗
42. Vikman J. · FASEB J. · 2009 · 23 · 5810.1096/fj.08-105734 ↗
43. Asfari M. · Endocrinology · 1992 · 130 · 16710.1210/endo.130.1.1370150 ↗